HemaSphere (Apr 2023)

5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

  • P. Bartolucci,
  • K.I. Ataga,
  • M. Callaghan,
  • L. De Franceschi,
  • C. Minniti,
  • A. Alexandrou,
  • D.-.C. Imbs,
  • R.P. Fox,
  • H. Patel,
  • A. Sostelly,
  • J. Schimmel

DOI
https://doi.org/10.1097/01.HS9.0000928292.81037.b2
Journal volume & issue
Vol. 7, no. S1
pp. 22 – 22

Abstract

Read online

No abstracts available.